Category: Allergan Inc.Syndicate content

Covidien acquires Reverse Medical | Medtech Wall Street news for the week of August 25, 2014

August 28, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

Allergan accedes to special meeting, asks court to block Valeant's vote

August 27, 2014 by Arezu Sarvestani

Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares.

Allergan accedes to special meeting, asks court to block Valeant's vote

Covidien acquires Reverse Medical | The week in medtech M&A

August 27, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien snaps up Reverse Medical; Report: Medtronic butts heads with shareholders at annual meeting; Allergan can't delay shareholder vote on hostile Valeant bid; Report: Allergan solicits Salix in bid to stymie hostile Valeant takeover; Report: Endo Health puts AMS up for sale

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

Valeant sues Allergan for special meeting after show of shareholder support

August 25, 2014 by Arezu Sarvestani

Valeant Pharmaceuticals files a lawsuit aiming to force Allergan to hold a special shareholder meeting after hand-delivering 1,500 pages of documents showing shareholder support.

Valeant files new lawsuit in Allergan acquisition saga

Mirowski asks Supreme Court to hear appeal in lawsuit against Medtronic | Medtech legal news for the week of August 25, 2014

August 25, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit; Shareholders sue InVivo Therapeutics, ex-CEO Reynolds over delayed FDA trial; Retractable Technologies urges appeals court to leave infringement win over BD alone; Boston Scientific can't sever Pinnacle pelvic mesh cases; Allergan can't delay shareholder vote on hostile Valeant bid

Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit

August 18, 2014 by Brad Perriello

Allergan can't delay shareholder vote on hostile Valeant bid

August 22, 2014 by Brad Perriello

Valeant Pharmaceuticals and Pershing Square Capital Management reportedly plan to ask Allergan for a shareholder vote on their hostile takeover attempt, after a federal judge rules that Allergan's insider trading lawsuit won't delay the meeting.

Allergan can't delay shareholder vote on hostile Valeant bid

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp